DescriptionFollowing on from its huge success in 2017, Oxford Global are proud to present their 2nd Annual Advances in Trangsgenic Technology USA Congress, 10-11 May, Boston, USA.
This event will host over 300 delegates from the leading research & academic institutions and clinical research in the USA as well as leading pharmaceutical and Biotech companies from around the globe.
World renowned experts will give over 20 presentations across 2 interactive streams, including;
• Technical Advances in Transgenic Genome Editing
• Transgenic Models of Disease and Therapeutic Applications
Presentations will focus on key issues in transgenic technologies including in-vivo CRISPR genome editing, translational applications using various animal models and transgenic models of oncology, cardiovascular disease and metabolic disorders.
This event will once again be co-located with the Genome Editing USA Congress which is also going into it’s second year. This year the congress will also be co-located with the highly anticipated inaugural Synthetic Biology USA Congress.
Free Pre-Congress Live Webinar
Latest CRISPR Genome Editing and Thereapeutic Applications of Mouse and Rat Models
Chengyu Liu, Core Director, Transgenic Core, National Heart, Lung, and Blood and Shanrong Zhao, Director Computational Biology and Bioinformatics, Pfizer
For further information, prices & discounts please contact firstname.lastname@example.org or click here: http://bit.ly/2hyCm0f
Alternatively visit our website http://bit.ly/2iiszvQ